APA (7th ed.) Citation

Cuker, A. (2023). The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness. Seminars in Thrombosis & Hemostasis, 49(1), 76. https://doi.org/10.1055/s-0042-1756709

Chicago Style (17th ed.) Citation

Cuker, Adam. "The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness." Seminars in Thrombosis & Hemostasis 49, no. 1 (2023): 76. https://doi.org/10.1055/s-0042-1756709.

MLA (9th ed.) Citation

Cuker, Adam. "The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness." Seminars in Thrombosis & Hemostasis, vol. 49, no. 1, 2023, p. 76, https://doi.org/10.1055/s-0042-1756709.